Related references
Note: Only part of the references are listed.Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
Palak J. Trivedi et al.
GUT (2016)
CXCR5+ CD4+ T Follicular Helper Cells Participate in the Pathogenesis of Primary Biliary Cirrhosis
Lifeng Wang et al.
HEPATOLOGY (2015)
Ongoing Activation of Autoantigen-Specific B Cells in Primary Biliary Cirrhosis
Jun Zhang et al.
HEPATOLOGY (2014)
Shotgun Proteomics: Identification of Unique Protein Profiles of Apoptotic Bodies From Biliary Epithelial Cells
Ana Lleo et al.
HEPATOLOGY (2014)
IL-12/Th1 and IL-23/Th17 Biliary Microenvironment in Primary Biliary Cirrhosis: Implications for Therapy
Chen-Yen Yang et al.
HEPATOLOGY (2014)
Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα-/- mice
Yuan Yao et al.
JOURNAL OF AUTOIMMUNITY (2014)
Murine autoimmune cholangitis requires two hits: Cytotoxic KLRG1+ CD8 effector cells and defective T regulatory cells
Wenting Huang et al.
JOURNAL OF AUTOIMMUNITY (2014)
Mechanisms of tissue injury in autoimmune liver diseases
Evaggelia Liaskou et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
Incidence of and Risk Factors for Hepatocellular Carcinoma in Primary Biliary Cirrhosis: National Data from Japan
Kenichi Harada et al.
HEPATOLOGY (2013)
Risk Factors of Hepatocellular Carcinoma - Current Status and Perspectives
Jing Gao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Disease-specific autoantibodies in primary biliary cirrhosis
Dimitrios P. Bogdanos et al.
CLINICA CHIMICA ACTA (2011)
Risk Factors and Prediction of Long-term Outcome in Primary Biliary Cirrhosis
Hiromi Ishibashi et al.
INTERNAL MEDICINE (2011)
PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis
Alessandro Granito et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Anna S. Lok et al.
GASTROENTEROLOGY (2010)
Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Primary Biliary Cirrhosis
Carole Macaron et al.
HEPATOLOGY (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Incidence, Risk Factors, and Survival of Hepatocellular Carcinoma in Primary Biliary Cirrhosis: Comparative Analysis from Two Centers
Anna Cavazza et al.
HEPATOLOGY (2009)
Primary Biliary Cirrhosis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study
K. Ikeda et al.
JOURNAL OF VIRAL HEPATITIS (2009)
General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007
Jian Lu et al.
PLOS ONE (2009)
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus
Shigeru Adachi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study
Kazuki Ikeda et al.
ANNALS OF INTERNAL MEDICINE (2007)
Occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2007)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Pathogenesis of hepatitis B virus-related hepatocellular carcinoma:: Old and new paradigms
C Bréchot
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma
K Ohba et al.
SURGERY TODAY (2004)
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis
A Shibuya et al.
HEPATOLOGY (2002)
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen:: Clinically significant or purely occult?
C Bréchot et al.
HEPATOLOGY (2001)
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease:: influence of HBsAg and anti-HCV status
F Trevisani et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
